Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$13,184,426
+$1,789,255 QoQ
Shares Held
52,394
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#789
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kintegral Advisory, LLC holds $82,893,440 across 8 Drug Manufacturers - General names. ABBV ranks #3 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,208 | $18,240,932 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
115,097 | $14,541,354 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
52,394 | $13,184,426 | |
| 4 | MRK |
Merck & Co., Inc.
|
91,933 | $11,813,390 | |
| 5 | AMGN |
Amgen Inc
|
29,489 | $10,678,556 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
116,111 | $6,690,315 | |
| 7 | BIIB |
Biogen Inc.
|
17,946 | $3,877,412 | |
| 8 | PFE |
Pfizer Inc
|
160,592 | $3,867,055 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,184,426 | 52,394 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $11,395,171 | 52,394 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $12,502,287 | 54,717 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $13,015,789 | 56,214 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $10,481,033 | 56,465 | Shares | Defined | 2025-07-25 | |
| 2025-03-31 | $11,848,356 | 56,550 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $10,082,698 | 56,740 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $11,726,954 | 59,383 | Shares | Defined | 2024-11-04 | |
| 2024-06-30 | $10,318,814 | 60,161 | Shares | Defined | 2024-07-26 | |
| 2024-03-31 | $9,779,680 | 53,705 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $8,348,543 | 53,872 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,081,138 | 54,214 | Shares | Defined | 2023-10-12 | |
| 2023-06-30 | $7,308,563 | 54,246 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $8,645,185 | 54,246 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $9,237,627 | 57,160 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,644,870 | 56,962 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $8,724,299 | 56,962 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $9,038,605 | 55,756 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,380,518 | 54,509 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $5,879,885 | 54,509 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $6,139,893 | 54,509 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,898,963 | 54,509 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $5,840,639 | 54,509 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $4,774,443 | 54,509 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,523,901 | 56,263 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,028,774 | 52,878 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||